- Home
- SHIP vs AVTX Comparison
SHIP vs AVTX Comparison
Compare SHIP & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- AVTX
- Stock Information
- Founded
- SHIP 2008
- AVTX 2011
- Country
- SHIP Greece
- AVTX United States
- Employees
- SHIP N/A
- AVTX N/A
- Industry
- SHIP Marine Transportation
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SHIP Consumer Discretionary
- AVTX Health Care
- Exchange
- SHIP Nasdaq
- AVTX Nasdaq
- Market Cap
- SHIP 153.8M
- AVTX 138.8M
- IPO Year
- SHIP 2007
- AVTX 2015
- Fundamental
- Price
- SHIP $8.23
- AVTX $11.50
- Analyst Decision
- SHIP Strong Buy
- AVTX Strong Buy
- Analyst Count
- SHIP 1
- AVTX 8
- Target Price
- SHIP $11.00
- AVTX $31.00
- AVG Volume (30 Days)
- SHIP 123.2K
- AVTX 214.6K
- Earning Date
- SHIP 11-04-2025
- AVTX 11-06-2025
- Dividend Yield
- SHIP 9.31%
- AVTX N/A
- EPS Growth
- SHIP N/A
- AVTX N/A
- EPS
- SHIP 0.73
- AVTX N/A
- Revenue
- SHIP $147,718,000.00
- AVTX $441,000.00
- Revenue This Year
- SHIP N/A
- AVTX N/A
- Revenue Next Year
- SHIP $12.15
- AVTX N/A
- P/E Ratio
- SHIP $10.97
- AVTX N/A
- Revenue Growth
- SHIP 1.66
- AVTX N/A
- 52 Week Low
- SHIP $4.78
- AVTX $3.39
- 52 Week High
- SHIP $12.65
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- SHIP 66.37
- AVTX 72.39
- Support Level
- SHIP $7.56
- AVTX $8.65
- Resistance Level
- SHIP $8.32
- AVTX $12.41
- Average True Range (ATR)
- SHIP 0.25
- AVTX 0.88
- MACD
- SHIP 0.02
- AVTX 0.12
- Stochastic Oscillator
- SHIP 91.26
- AVTX 80.00
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Geniuship, Premiership, Squireship, And Friendship.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).